Reply to 'Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance'.
我要评论
本期排行
- HER-2 intratumoral heterogenei...
- Reply to 'The new molecular ma...
- DDIT3, STT3A (ITM1), ARG2 and ...
- MicroRNAs as prognostic marker...
- Letter to the editor regarding...
- Reply to 'Intratumoral heterog...
- Molecular pathological epidemi...
- Frequency of mutations and pol...
- Clinicopathologic analysis of ...
- Endometrium is not the primary...
共0条评论